Literature DB >> 21632895

Practical approach for reliable detection of AmpC beta-lactamase-producing Enterobacteriaceae.

Silke Polsfuss1, Guido V Bloemberg, Jacqueline Giger, Vera Meyer, Erik C Böttger, Michael Hombach.   

Abstract

In this prospective study all Enterobacteriaceae isolates (n = 2,129) recovered in the clinical microbiology laboratory during October 2009 to April 2010 were analyzed for AmpC production. Clinical and Laboratory Standards Institute (CLSI) cefoxitin and cefotetan susceptibility breakpoints and CLSI critical ESBL diameters were used to screen for potential AmpC producers. In total, 305 isolates (211 potential AmpC producers and 94 AmpC screen-negative isolates as a control group) were further analyzed by multiplex PCR for the detection of plasmid-encoded ampC beta-lactamase genes and by ampC promoter sequence analysis (considered as the gold standard). Cefoxitin and cefotetan were assessed as primary screening markers. The sensitivities of cefoxitin and cefotetan for the detection of AmpC production were 97.4 and 52.6%, respectively, and the specificities were 78.7 and 99.3%, respectively. As a phenotypic confirmation test, the Etest AmpC and the cefoxitin-cloxacillin double-disk synergy method (CC-DDS) were compared. The sensitivities for the Etest AmpC and the CC-DDS method were 77.4 and 97.2%, respectively, and the specificity was 100% for both methods. The results of the Etest AmpC were inconclusive for 10 isolates. With the CC-DDS method 2 inconclusive results were observed. Based on this study, we propose a comprehensive diagnostic flow chart for the detection of AmpC production consisting of a simple phenotypic screening and a single phenotypic confirmation test with inconclusive results being resolved by molecular analysis. For the proposed flow chart using (i) cefoxitin as a screening marker for AmpC production, (ii) the CC-DDS method as phenotypic confirmation, and (iii) molecular methods in case of inconclusive results, the sensitivity and specificity for AmpC detection would have been 97.4 and 100%, respectively, with respect to the studied isolates. The phenotypic methods used in the AmpC algorithm are simple to perform and easy to implement in the diagnostic laboratory.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21632895      PMCID: PMC3147735          DOI: 10.1128/JCM.00404-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  27 in total

Review 1.  Plasmid-determined AmpC-type beta-lactamases.

Authors:  Alain Philippon; Guillaume Arlet; George A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

2.  Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR.

Authors:  F Javier Pérez-Pérez; Nancy D Hanson
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

3.  High-level expression of ampC beta-lactamase due to insertion of nucleotides between -10 and -35 promoter sequences in Escherichia coli clinical isolates: cases not responsive to extended-spectrum-cephalosporin treatment.

Authors:  L K Siu; Po-Liang Lu; J-Y Chen; F M Lin; Shan-Chwen Chang
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

4.  Prevalence of acquired AmpC beta-lactamases in Enterobacteriaceae lacking inducible chromosomal ampC genes at a Spanish hospital from 1999 to 2007.

Authors:  C Mata; E Miró; A Rivera; B Mirelis; P Coll; F Navarro
Journal:  Clin Microbiol Infect       Date:  2009-06-11       Impact factor: 8.067

5.  Molecular mechanisms of cefoxitin resistance in Escherichia coli from the Toronto area hospitals.

Authors:  K R Forward; B M Willey; D E Low; A McGeer; M A Kapala; M M Kapala; L L Burrows
Journal:  Diagn Microbiol Infect Dis       Date:  2001 Sep-Oct       Impact factor: 2.803

Review 6.  Regulation of inducible AmpC beta-lactamase expression among Enterobacteriaceae.

Authors:  N D Hanson; C C Sanders
Journal:  Curr Pharm Des       Date:  1999-11       Impact factor: 3.116

7.  Molecular basis of AmpC hyperproduction in clinical isolates of Escherichia coli.

Authors:  E C Nelson; B G Elisha
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

8.  Epidemiology and clinical features of bloodstream infections caused by AmpC-type-beta-lactamase-producing Klebsiella pneumoniae.

Authors:  Hyunjoo Pai; Cheol-In Kang; Jeong-Hum Byeon; Ki-Deok Lee; Wan Beom Park; Hong-Bin Kim; Eui-Chong Kim; Myoung-Don Oh; Kang-Won Choe
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

9.  The inhibition of class C beta-lactamases by boronic acids.

Authors:  T Beesley; N Gascoyne; V Knott-Hunziker; S Petursson; S G Waley; B Jaurin; T Grundström
Journal:  Biochem J       Date:  1983-01-01       Impact factor: 3.857

Review 10.  Controversies about extended-spectrum and AmpC beta-lactamases.

Authors:  K S Thomson
Journal:  Emerg Infect Dis       Date:  2001 Mar-Apr       Impact factor: 6.883

View more
  53 in total

1.  Evaluation of the Rapidec Carba NP Test for Detection of Carbapenemases in Enterobacteriaceae.

Authors:  Michael Hombach; Barbara von Gunten; Claudio Castelberg; Guido V Bloemberg
Journal:  J Clin Microbiol       Date:  2015-09-30       Impact factor: 5.948

2.  Prospective evaluation of a screening algorithm for carbapenemase-producing Enterobacteriaceae.

Authors:  Morgane Choquet; Raphaël Guiheneuf; Sandrine Castelain; Emilie Pluquet; Véronique Decroix
Journal:  J Clin Lab Anal       Date:  2018-11-02       Impact factor: 2.352

Review 3.  A Primer on AmpC β-Lactamases: Necessary Knowledge for an Increasingly Multidrug-resistant World.

Authors:  Pranita D Tamma; Yohei Doi; Robert A Bonomo; J Kristie Johnson; Patricia J Simner
Journal:  Clin Infect Dis       Date:  2019-09-27       Impact factor: 9.079

4.  Integrating forecast probabilities in antibiograms: a way to guide antimicrobial prescriptions more reliably?

Authors:  Florian P Maurer; Patrice Courvalin; Erik C Böttger; Michael Hombach
Journal:  J Clin Microbiol       Date:  2014-08-06       Impact factor: 5.948

5.  The MAST® D68C test: an interesting tool for detecting extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae.

Authors:  C Nourrisson; R N Tan; C Hennequin; L Gibold; R Bonnet; F Robin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-01-14       Impact factor: 3.267

6.  Comparison of MALDI-ToF MS with the Rapidec Carba NP test for the detection of carbapenemase-producing Enterobacteriaceae.

Authors:  M Choquet; R Guiheneuf; S Castelain; V Cattoir; M Auzou; E Pluquet; V Decroix
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-10-04       Impact factor: 3.267

7.  Antibiotic-Resistant Escherichia coli in Migratory Birds Inhabiting Remote Alaska.

Authors:  Andrew M Ramey; Jorge Hernandez; Veronica Tyrlöv; Brian D Uher-Koch; Joel A Schmutz; Clara Atterby; Josef D Järhult; Jonas Bonnedahl
Journal:  Ecohealth       Date:  2017-12-11       Impact factor: 3.184

8.  A statistical approach for determination of disk diffusion-based cutoff values for systematic characterization of wild-type and non-wild-type bacterial populations in antimicrobial susceptibility testing.

Authors:  Giorgia Valsesia; Malgorzata Roos; Erik C Böttger; Michael Hombach
Journal:  J Clin Microbiol       Date:  2015-03-11       Impact factor: 5.948

9.  Prevalence of extended-spectrum β-lactamase-producing Escherichia coli on Bavarian dairy and beef cattle farms.

Authors:  A Schmid; S Hörmansdorfer; U Messelhäusser; A Käsbohrer; C Sauter-Louis; R Mansfeld
Journal:  Appl Environ Microbiol       Date:  2013-03-01       Impact factor: 4.792

10.  Role of TEM-1 β-Lactamase in the Predominance of Ampicillin-Sulbactam-Nonsusceptible Escherichia coli in Japan.

Authors:  Taro Noguchi; Yasufumi Matsumura; Toru Kanahashi; Michio Tanaka; Yasuhiro Tsuchido; Takuro Matsumura; Satoshi Nakano; Masaki Yamamoto; Miki Nagao; Satoshi Ichiyama
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.